TRIMU 5
Names | |
---|---|
IUPAC name
L-tyrosyl-N-{[(3-methylbutyl)amino]acetyl}-D-alaninamide | |
Other names
(2S)-2-amino-3-(4-hydroxyphenyl)-N-[(2R)-1-{[2-(3-methylbutylamino)acetyl]amino}-1-oxopropan-2-yl]propanamide | |
Identifiers | |
90815-77-3 | |
3D model (Jmol) | Interactive image |
ChemSpider | 21106389 |
PubChem | 5487273 |
| |
| |
Properties | |
C19H30N4O4 | |
Molar mass | 378.466 |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
verify (what is ?) | |
Infobox references | |
TRIMU 5 is a selective agonist of the mu opioid receptor type 2.[1]
References
- ↑ Eisenberg RM (1994). "TRIMU-5, a mu 2-opioid receptor agonist, stimulates the hypothalamo-pituitary-adrenal axis". Pharmacol. Biochem. Behav. 47 (4): 943–6. doi:10.1016/0091-3057(94)90300-X. PMID 8029266.
This article is issued from Wikipedia - version of the 7/7/2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.